BAYRY:OTC-Bayer Aktiengesellschaft (USD)

COMMON STOCK | Drug Manufacturers-General | OTC

Last Closing Price

USD 16.59

Change

-0.36 (-2.12)%

Market Cap

USD 66.61B

Volume

0.32M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

Bayer Aktiengesellschaft (BAYRY) Stock Analysis:
Based on the Bayer Aktiengesellschaft stock forecasts from 0 analysts, the average analyst target price for Bayer Aktiengesellschaft is not available over the next 12 months. Bayer Aktiengesellschaft’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bayer Aktiengesellschaft is Bearish, which is based on 3 positive signals and 11 negative signals. At the last closing, Bayer Aktiengesellschaft’s stock price was USD 16.59. Bayer Aktiengesellschaft’s stock price has changed by +9.79% over the past week, -7.94% over the past month and -3.15% over the last year.

No recent analyst target price found for Bayer Aktiengesellschaft
No recent average analyst rating found for Bayer Aktiengesellschaft

About

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health ...Read More

Company Website : https://www.bayer.com

Address : Kaiser-Wilhelm-Allee 1, Leverkusen, Germany, 51368

Employees : 95,950

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 1.19

52 Week High : 17.84

52 Week Low : 12.07

200 Day Moving Average : 14.69

Shorted Shares Previous Month : 611,188

50 Day Moving Average : 16.69

Shares Held by Institutions : 0.03%

Dividend Yield : 3.10%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-18 )

Largest Industry Peers for Drug Manufacturers-General

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RHHVF Roche Holding AG

-0.03 (-0.01%)

 USD286.72B 19.97 13.47
RHHBY Roche Holding AG

-0.03 (-0.07%)

 USD280.39B 19.87 13.30
RHHBF Roche Holding AG

+21.00 (+5.96%)

 USD279.99B 21.82 13.47
AZNCF AstraZeneca PLC

-3.73 (-2.89%)

 USD200.22B 1,636.08 31.26
NVSEF Novartis AG

N/A

 USD194.27B 8.11 6.24
SNYNF Sanofi

+0.57 (+0.56%)

 USD132.11B 18.35 13.86
GLAXF GlaxoSmithKline plc

N/A

 USD109.81B 17.46 13.54
BAYZF Bayer Aktiengesellschaft

+0.84 (+1.27%)

 USD64.58B 60.61 12.69
CHGCY Chugai Pharmaceutical Co. Ltd

+0.12 (+0.88%)

 USD45.68B 15.03 0.08
CHGCF Chugai Pharmaceutical Co. Ltd

N/A

 USD45.33B 15.16 0.08

ETFs Containing BAYRY

Symbol Name Weight Mer Price(Change) Market Cap
DBGR Xtrackers MSCI Germany He.. 0.00 % 0.45 %

-0.73 (-2.57%)

 USD9.93M
C006:XETRA Lyxor F.A.Z. 100 Index (D.. 0.00 % 0.25 %

-0.35 (-1.24%)

 USD0.08B
ELF0:XETRA Deka DAX ex Financials 30.. 0.00 % 0.30 %

-0.35 (-1.37%)

 USD0.03B
EL4F:XETRA Deka DAX (ausschüttend) .. 0.00 % 0.15 %

-0.78 (-1.31%)

 USD0.87B
EL4A:XETRA Deka DAX UCITS ETF 0.00 % 0.15 %

-1.68 (-1.32%)

 USD1.10B
EESM:XETRA BNP Paribas Easy - MSCI E.. 0.00 % 0.13 %

-2.80 (-1.03%)

 USD0.24B
E903:XETRA Lyxor 1 - DivDAX UCITS ET.. 0.00 % 0.25 %

-1.54 (-0.86%)

 USD0.05B
E901:XETRA Lyxor 1 DAX UCITS ETF (I) 0.00 % 0.15 %

N/A

 USD0.11B
DBXD:XETRA Xtrackers - DAX UCITS ETF 0.00 % 0.09 %

-1.74 (-1.29%)

 USD3.84B
CEUG:XETRA Amundi Index Solutions - .. 0.00 % 0.05 %

-3.45 (-1.26%)

 USD1.98B
C068:XETRA ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

 USD0.08B
C003:XETRA Lyxor DivDAX (DR) UCITS E.. 0.00 % 0.25 %

-0.26 (-0.82%)

 USD0.07B
EXV4:XETRA iShares (DE) I - iShares .. 0.00 % 0.46 %

-1.20 (-1.16%)

 USD0.82B
C002:XETRA ComStage - FR DAX UCITS E.. 0.00 % 0.15 %

N/A

 USD0.05B
C001:XETRA Lyxor Core DAX (DR) UCITS.. 0.00 % 0.25 %

-1.60 (-1.34%)

 USD0.91B
XDDX:F Xtrackers - DAX Income UC.. 0.00 % 0.19 %

-0.62 (-0.58%)

 USD0.42B
WTEZ:F WisdomTree Issuer ICAV - .. 0.00 % 0.32 %

N/A

 N/A
WTEE:F WisdomTree Europe Equity .. 0.00 % 0.29 %

+0.01 (+0.06%)

 USD0.02B
VX5E:F Vanguard Euro STOXX 50 UC.. 0.00 % 0.00 %

N/A

 USD0.04B
SPYW:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.30 %

-0.02 (-0.09%)

 USD1.05B
SPYH:F SSgA SPDR ETFs Europe II .. 0.00 % 0.18 %

-0.76 (-0.40%)

 USD0.69B
LYY7:F Multi Units Luxembourg - .. 0.00 % 0.15 %

-0.30 (-0.23%)

 USD0.66B
IQQV:F iShares Euro Total Market.. 0.00 % 0.40 %

N/A

 USD0.03B
EXSB:XETRA iShares DivDAX UCITS ETF .. 0.00 % 0.31 %

-0.13 (-0.72%)

 USD0.50B
FRCA:XETRA UBS ETF - MSCI EMU hedged.. 0.00 % 0.28 %

N/A

 USD0.35B
EXSB:F iShares DivDAX UCITS ETF .. 0.00 % 0.31 %

N/A

 USD0.50B
ZGEN:CA BMO MSCI Genomic Innovati.. 0.00 % 0.40 %

-0.34 (-1.72%)

 N/A
ESIH:LSE Ishares VI PLC - Ishares .. 0.00 % 0.18 %

-0.03 (-0.60%)

 N/A
VGER:F Vanguard Funds Public Lim.. 0.00 % 0.10 %

N/A

 N/A
E909:F Lyxor 1 DAX® 50 ESG UCIT.. 0.00 % 0.05 %

N/A

 N/A
JPHU:LSE Amundi Index Solutions - .. 0.00 % 0.08 %

-1.68 (-0.84%)

 N/A
JPHG:LSE Amundi Index Solutions - .. 0.00 % 0.08 %

-161.00 (-0.85%)

 N/A
VGER:XETRA Vanguard Germany All Cap .. 0.00 % 0.10 %

-0.32 (-1.32%)

 USD0.12B
ELFG:XETRA Deka Germany 30 UCITS ETF 0.00 % 0.09 %

-11.60 (-0.79%)

 USD0.52B
E909:XETRA Lyxor 1 DAX® 50 ESG UCIT.. 0.00 % 0.05 %

-0.50 (-1.43%)

 USD0.20B
AMEC:XETRA Amundi Index Solutions - .. 0.00 % 0.25 %

-0.71 (-1.30%)

 USD0.02B
EXS1:XETRA iShares Core DAX UCITS ET.. 0.00 % 0.16 %

-1.58 (-1.32%)

 USD7.08B
GOAI:XETRA Amundi Stoxx Global Artif.. 0.00 % 0.25 %

-1.11 (-1.47%)

 USD0.37B
XDDX:XETRA Xtrackers - DAX Income UC.. 0.00 % 0.19 %

-1.42 (-1.33%)

 USD0.42B
X503:XETRA ComStage - iBOXX Euro Liq.. 0.00 % 0.12 %

N/A

 USD5.98M
WTEZ:XETRA WisdomTree Germany Equity.. 0.00 % 0.32 %

N/A

 N/A
WTEE:XETRA WisdomTree Europe Equity .. 0.00 % 0.29 %

-0.08 (-0.62%)

 USD0.02B
VX5E:XETRA Vanguard Euro STOXX 50 UC.. 0.00 % 0.00 %

N/A

 USD0.04B
VDXX:XETRA Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

 USD0.12B
SPYH:XETRA SSgA SPDR ETFs Europe II .. 0.00 % 0.18 %

-1.86 (-0.97%)

 USD0.61B
MIVU:XETRA Amundi Index Solutions - .. 0.00 % 0.08 %

-1.29 (-1.72%)

 USD0.39B
LYY7:XETRA Multi Units Luxembourg - .. 0.00 % 0.15 %

-1.74 (-1.32%)

 USD0.66B
IQQV:XETRA iShares Euro Total Market.. 0.00 % 0.40 %

N/A

 USD0.03B
EXV4:F iShares (DE) I - iShares .. 0.00 % 0.46 %

-0.44 (-0.43%)

 USD0.82B
ELF0:F Deka DAX ex Financials 30.. 0.00 % 0.30 %

+0.03 (+0.10%)

 USD0.03B
DXGE WisdomTree Germany Hedged.. 0.00 % 0.58 %

-0.45 (-1.31%)

 USD0.03B
DXGY:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.32 %

N/A

 N/A
UC89:LSE UBS ETF - MSCI EMU hedged.. 0.00 % 0.28 %

N/A

 USD0.35B
S6EW:LSE Ossiam Lux - Ossiam Stoxx.. 0.00 % 0.35 %

-1.37 (-1.26%)

 USD0.28B
L6EW:LSE Ossiam Lux - Ossiam Stoxx.. 0.00 % 0.35 %

-98.50 (-1.07%)

 USD0.29B
IEVL:LSE iShares IV Public Limited.. 0.00 % 0.25 %

-0.06 (-0.78%)

 USD3.58B
IEFV:LSE iShares IV Public Limited.. 0.00 % 0.25 %

-2.60 (-0.42%)

 USD3.58B
IEDL:LSE iShares Edge MSCI Europe .. 0.00 % 0.25 %

-0.03 (-0.62%)

 USD3.16B
IDJV:LSE iShares Euro Total Market.. 0.00 % 0.40 %

N/A

 USD0.03B
HLTH:LSE SSgA SPDR ETFs Europe II .. 0.00 % 0.18 %

-1.44 (-0.76%)

 USD0.69B
DXGZ:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.32 %

N/A

 N/A
DXGP:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.35 %

N/A

 N/A
XCX5:LSE Xtrackers - MSCI India Sw.. 0.00 % 0.75 %

-9.75 (-0.79%)

 USD0.07B
DXGG:LSE WisdomTree Germany Equity.. 0.00 % 0.48 %

N/A

 N/A
DXGE:LSE WisdomTree Germany Equity.. 0.00 % 0.48 %

N/A

 N/A
CEUR:LSE Amundi Index Solutions - .. 0.00 % 0.05 %

-260.00 (-1.13%)

 USD1.98B
ZDEU SPDR Solactive Germany ET.. 0.00 % 0.14 %

N/A

 USD0.03B
FLGR Franklin FTSE Germany ETF 0.00 % 0.09 %

-0.64 (-3.11%)

 USD0.01B
ZVI:CA BMO MSCI EAFE Value Index.. 0.00 % 0.40 %

N/A

 USD3.93M
MOO VanEck Vectors Agribusine.. 0.00 % 0.55 %

-3.41 (-3.45%)

 USD1.93B
IVLU iShares Edge MSCI Intl Va.. 0.00 % 0.30 %

-0.43 (-1.76%)

 USD1.30B
HEWG iShares Trust - iShares C.. 0.00 % 0.53 %

-0.73 (-2.55%)

 USD0.04B
EWG iShares MSCI Germany ETF 0.00 % 0.50 %

-0.90 (-3.40%)

 USD1.67B
XCS5:LSE Xtrackers - MSCI India Sw.. 0.00 % 0.75 %

-0.20 (-1.29%)

 USD0.07B
XLDX:LSE Xtrackers - LevDAX Daily .. 0.00 % 0.35 %

-239.00 (-2.36%)

 USD0.06B
EL4F:F Deka DAX (ausschüttend) .. 0.00 % 0.15 %

-0.20 (-0.34%)

 USD0.87B
C003:F Lyxor DivDAX® (DR) UCITS.. 0.00 % 0.25 %

+0.12 (+0.39%)

 USD0.07B
EL4A:F Deka DAX UCITS ETF 0.00 % 0.15 %

+0.32 (+0.25%)

 USD1.10B
E903:F Lyxor 1 - DivDAX UCITS ET.. 0.00 % 0.25 %

+0.66 (+0.37%)

 USD0.05B
E901:F Lyxor 1 DAX UCITS ETF (I) 0.00 % 0.15 %

N/A

 USD0.10B
DBXD:F Xtrackers - DAX UCITS ETF 0.00 % 0.09 %

-1.00 (-0.74%)

 USD3.84B
DBPD:F Xtrackers - ShortDAX x2 D.. 0.00 % 0.60 %

-0.01 (-0.46%)

 USD0.15B
D5BL:F Xtrackers - MSCI Europe V.. 0.00 % 0.15 %

+0.08 (+0.28%)

 USD0.05B
CEMS:F iShares IV Public Limited.. 0.00 % 0.25 %

+0.02 (+0.29%)

 USD3.58B
C068:F ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

 USD0.08B
C006:F Lyxor F.A.Z. 100 Index (D.. 0.00 % 0.25 %

+0.08 (+0.29%)

 USD0.08B
C002:F ComStage FR DAX UCITS ETF 0.00 % 0.15 %

N/A

 USD0.05B
XSPD:LSE Xtrackers - S&P 500 Inver.. 0.00 % 0.50 %

+0.17 (+1.94%)

 USD0.19B
C001:F Lyxor Core DAX® (DR) UCI.. 0.00 % 0.25 %

+0.06 (+0.05%)

 USD0.91B
STW:PA SSgA SPDR ETFs Europe II .. 0.00 % 0.18 %

-1.90 (-0.99%)

 USD0.61B
MIVU:PA Amundi Index Solutions - .. 0.00 % 0.08 %

-1.34 (-1.78%)

 USD0.39B
EUDV:PA SSgA SPDR ETFs Europe I P.. 0.00 % 0.30 %

-0.20 (-0.91%)

 USD1.05B
EESM:PA BNP Paribas Easy MSCI Eur.. 0.00 % 0.13 %

-2.27 (-0.83%)

 USD0.24B
DAX:PA Multi Units Luxembourg - .. 0.00 % 0.15 %

-1.66 (-1.26%)

 USD0.59B
CG1:PA Amundi ETF DAX UCITS ETF .. 0.00 % 0.10 %

-3.05 (-1.19%)

 USD0.51B
VX5E:LSE Vanguard Euro STOXX 50 UC.. 0.00 % 0.00 %

N/A

 USD0.04B
VDXX:LSE Vanguard Germany All Cap .. 0.00 % 0.00 %

N/A

 USD0.04B
XSPS:LSE Xtrackers - S&P 500 Inver.. 0.00 % 0.50 %

+17.25 (+2.53%)

 USD0.19B
ESIH:XETRA iShares MSCI Europe Healt.. 0.00 % 0.18 %

-0.06 (-0.98%)

 N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers-General)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.11% 97% A+ 88% B+
Dividend Return 4.14% 75% C 72% C-
Total Return 29.25% 89% B+ 87% B+
Trailing 12 Months  
Capital Gain -2.12% 58% F 71% C-
Dividend Return 3.24% 65% D 44% F
Total Return 1.12% 56% F 70% C-
Trailing 5 Years  
Capital Gain -49.24% 8% F 32% F
Dividend Return 10.59% 50% F 36% F
Total Return -38.65% 12% F 36% F
Average Annual (5 Year Horizon)  
Capital Gain -15.17% 8% F 9% F
Dividend Return 3.50% 67% D+ 65% D
Total Return -11.67% 8% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 18.99% 65% D 84% B
Risk Adjusted Return -61.45% 5% F 6% F
Market Capitalization 66.61B 81% B- 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers-General)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 63.78 22% F 9% F
Price/Book Ratio 1.57 70% C- 49% F
Price / Cash Flow Ratio 13.09 38% F 13% F
EV/EBITDA 12.69 41% F 23% F
Management Effectiveness  
Return on Equity 3.20% 14% F 44% F
Return on Invested Capital 8.27% 49% F 65% D
Return on Assets 3.77% 30% F 74% C
Debt to Equity Ratio 107.66% 14% F 15% F
Technical Ratios  
Dividend Yield 3.10% 64% D 43% F
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.19 3% F 35% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector